Siga Technologies (SIGA) Accumulated Expenses (2010 - 2025)
Siga Technologies (SIGA) posted Accumulated Expenses of $6.5 million for Q4 2025, up 137.76% on a QoQ basis from $2.7 million in Q3 2025, and up 922.35% year-over-year from $637750.0 in Q4 2024.
Siga Technologies (SIGA) Accumulated Expenses (2010 - 2025) Analysis & Trends
Siga Technologies' Accumulated Expenses history runs 16 years deep, the most recent figure standing at $6.5 million for Q4 2025.
- Quarterly Accumulated Expenses rose 922.35% year-over-year to $6.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.5 million (up 922.35% YoY) and the FY2025 annual result came in at $6.5 million, up 922.35% from the prior year.
- Accumulated Expenses was $6.5 million for Q4 2025 at Siga Technologies, up from $2.7 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $30.1 million in Q3 2023 and bottomed at $637750.0 in Q4 2024.
- A 5-year average of $6.6 million and a median of $3.1 million in 2021 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2021 — Accumulated Expenses soared 1563.26% — and 2024, when it tumbled 93.03%.
- Siga Technologies' Accumulated Expenses stood at $2.8 million in 2021, then soared by 124.21% to $6.3 million in 2022, then plunged by 46.62% to $3.4 million in 2023, then sank by 81.05% to $637750.0 in 2024, then soared by 922.35% to $6.5 million in 2025.
- Business Quant data shows SIGA's Accumulated Expenses at $6.5 million in Q4 2025, $2.7 million in Q3 2025, and $7.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Siga Technologies | 225.56 Mn | 70.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.52 Mn |
| Sep 30, 2025 | 2.74 Mn |
| Jun 30, 2025 | 7.11 Mn |
| Mar 31, 2025 | 16.23 Mn |
| Dec 31, 2024 | 637,750.00 |
| Sep 30, 2024 | 2.10 Mn |
| Jun 30, 2024 | 6.53 Mn |
| Mar 31, 2024 | 1.37 Mn |
| Dec 31, 2023 | 3.37 Mn |
| Sep 30, 2023 | 30.13 Mn |
| Jun 30, 2023 | 17.89 Mn |
| Mar 31, 2023 | 801,890.00 |
| Dec 31, 2022 | 6.30 Mn |
| Sep 30, 2022 | 2.00 Mn |
| Jun 30, 2022 | 14.84 Mn |
| Mar 31, 2022 | 716,680.00 |
| Dec 31, 2021 | 2.81 Mn |
| Sep 30, 2021 | 2.42 Mn |
| Jun 30, 2021 | 7.30 Mn |
| Mar 31, 2021 | 853,833.00 |